# AV650 Drug-Drug Interaction Study

> **NCT00456560** · PHASE1 · COMPLETED · sponsor: **Avigen** · enrollment: 30 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AV650
- **DRUG:** Fluvoxamine
- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT00456560
- **Lead sponsor:** Avigen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456560, "AV650 Drug-Drug Interaction Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00456560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*